PSH · Financial services · one day
Pershing Square Holdings (PSH): news on Tuesday 10 November 2026
News from the 24 hours to Tuesday morning, 10 November 2026.
Tone of the day
What the score means. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.
Why it scored this way
Relevant coverage centred on Pershing Square's backing of Alcon ahead of its results, plus a piece on Bill Ackman's plan for brain research. Both are mildly positive for the fund.
What drove it
- Alcon stake
- Ackman brain research plan
Around this day
| Day | Tone | Headlines |
|---|---|---|
| Wed 4 Nov | +1.2 | 22 |
| Thu 5 Nov | +2.5 | 16 |
| Fri 6 Nov | +4.5 | 5 |
| Sat 7 Nov | +3.0 | 4 |
| Sun 8 Nov | −1.7 | 1 |
| Tue 10 Nov | +5.7 | 3 |
| Wed 11 Nov | −7.5 | 4 |
| Thu 12 Nov | +2.5 | 1 |
| Fri 13 Nov | +2.3 | 3 |
2 stories · 3 headlines · strongest first
Financial services on 10 NovemberFTSE 100 that day| Tone | What the article reported, and why it scored that way | |
|---|---|---|
| Pershing Square backs Alcon before 10 November results +5.12 headlines today · 4 in all, since 7 November · Ad-hoc-news pieces cover Alcon ahead of results with Pershing Square support. | ||
| +6.3 | Fund's backing lifted Alcon shares before results, a positive for its holding. | |
| +5.8 | Fund's stake in Alcon and its support seen as constructive. | |
| Ackman plan for brain research +5.01 headline today · STAT reports on Bill Ackman's plan to change brain research. | ||
| +5.0 | Ackman's brain research initiative gives modestly positive profile to the fund's leadership. | |
Each article has its own score. The lines are our own summary; follow the source link to read the article itself.
Follow by email
A short, free morning email on how the news treated Pershing Square Holdings: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.